| Heating pains: Aid still available to offset high cost of staying warm in the Granite State
From piling on extra sweaters to closing off rooms to cranking up wood stoves and space heaters, New Hampshire residents remain locked in a bitter battle against crushing home heating costs and a winter that won't acknowledge spring. "It's hard. Very hard," said Lillian Provencher, a 72-year-old widow who lives alone in Bedford. "I lived here all my life. I paid taxes all my life. And what I get in fuel assistance doesn't even pay for a full tank of oil,'' said Provencher, a retired home-care provider and clothing mill worker. "Pretty soon, it's going to be between medicine and oil." The $525 Provencher said she received in fuel assistance this winter bought a mere 168 gallons, hardly topping the halfway mark on her tank. She paid for the remainder of her oil from her pension and Social Security or, if need be, her savings.
'American Experience: Roberto Clemente'
I am the proof that you don't have to know much or care deeply about baseball to be thrilled and moved by the story of Roberto Clemente, right fielder, family man, humanitarian, Pittsburgh Pirate, Puerto Rican.
Bernardo Ruiz's lovely and exciting "Roberto Clemente," airing tonight on PBS as part of "American Experience," tells the story of a man who by every account was as effortlessly upright and true as if he were crafted for juvenile fiction, a man who never forgot who he was, where he came from and what mattered. He died young in a plane crash, in 1972 at age 38, delivering medical supplies to earthquake victims in Nicaragua.
.
Health Calendar: 04/10/2008
The Health calendar is published weekly. Information to be included can be mailed to the Record-Eagle, P.O. Box 632, Traverse City, MI 49685; faxed to 946-8632; e-mailed to gmurray@record-eagle.com or delivered to: 120 W. Front St. Traverse City. MICHIGAN COMMUNITY BLOOD CENTER Acme, 3-7 p.m. April 10, Holiday Shopper, US-31 S. & Bunker Hill Road, bus. Alba, 1-5 p.m. April 18, Alba School, 5935 Elm St., bus. Empire, 4-7 p.m. April 15, St. Philip Neri Church, 11411 LaCore Ave., bus. Frankfort, 1-4 p.m. April 14, The Maples, 210 Maple Ave., bus. Kalkaska, 2-6 p.m. April 10, Kalkaska Memorial Health Center, 419 S. Coral. Kingsley, 9:30 a.m.-3 p.m. April 11, Kingsley High School, 7475 Kingsley Road, bus.
WAND and Synaptica from Dow Jones Target Personal Care and Beauty Online Retailers With Pre-packaged Taxonomy and ...
Managing product data now easier than ever for the personal care and beauty industry. Attribute based navigation to improve user interface and increase conversions and average tickets can now be easily enabled on a personal care and beauty retail website. Denver, CO (PRWEB) April 24, 2008 -- WAND, Inc is now delivering its 1,246 term Personal Care and Beauty product taxonomy integrated with the industry leading Synaptica taxonomy management software. This combined package will be a valuable tool for personal care and beauty retailers who want to improve their online retail presence. A well-structured taxonomy with attribute level detail can improve a personal care and beauty sites by increasing conversions, improving the user interface, and increasing average transaction value.
FDA Approves Cimzia To Treat Crohn's Disease
A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.
Crohn's disease is a chronic, inflammatory bowel disease that affects more than 1 million men and women worldwide. It has no cure and its cause is unknown. Crohn's can cause diarrhea, fever, rectal bleeding, malnutrition, narrowing of the intestinal tract, obstructions, abscesses, cramping, and abdominal pain. It also can lead to abnormal connections (fistulas) leading from the intestine to the skin or internal organs.
"Crohn's is a debilitating disease that disrupts the quality of life for its sufferers," said Julie Beitz, M.D., director of the Office of Drug Evaluation III for the FDA's Center for Drug Evaluation and Research.
|
